Human Kallikrein 13 (KLK13) activation kit by CRISPRa
CAT#: GA108741
KLK13 CRISPRa kit - CRISPR gene activation of human kallikrein related peptidase 13
Find the corresponding CRISPRi Inhibitor Kit
USD 1,290.00
2 Weeks*
Specifications
Product Data | |
Format | 3gRNAs, 1 scramble ctrl and 1 enhancer vector |
Symbol | KLK13 |
Locus ID | 26085 |
Kit Components | GA108741G1, KLK13 gRNA vector 1 in pCas-Guide-CRISPRa GA108741G2, KLK13 gRNA vector 2 in pCas-Guide-CRISPRa GA108741G3, KLK13 gRNA vector 3 in pCas-Guide-CRISPRa 1 CRISPRa-Enhancer vector, SKU GE100056 1 CRISPRa scramble vector, SKU GE100058 |
Disclaimer | The kit is designed based on the best knowledge of CRISPa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc. |
Reference Data | |
RefSeq | NM_015596, NM_001348177, NM_001348178, NR_145463, NR_145464, NR_145465, NR_145466, NR_145467 |
Synonyms | KLK-L4; KLKL4 |
Summary | Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Expression of this gene is regulated by steroid hormones and may be useful as a marker for breast cancer. [provided by RefSeq, Jan 2017] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
KN410136 | KLK13 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. |
USD 1,290.00 |
{0} Product Review(s)
Be the first one to submit a review